Fidelity Adv Biotech-IFBTIX
13F holders, Q4 2025 (December 31)1holders −1
0new positions
1sold out
$41.27avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Fidelity Adv Biotech-I (FBTIX) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holder was Sequent Asset Management, LLC ($824K).
- Company
- Fidelity Adv Biotech-I
- CUSIP
- 315918466
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $36K |
All 13F filers, Q3 2025 → Q4 2025: 267 shares bought and 981 shares sold, net −714 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Sequent Asset Management, LLC | 0.37% | Add +1.4% | 19,965 | $824K |
"% of holder's portfolio" is FBTIX's weight in each manager's 13F, not the share of Fidelity Adv Biotech-I the manager owns.